-
Mashup Score: 1
Skip to content Home Confirmed international speakers Australian Invited Speakers Accommodation Conference Venue Equity statement Registration Past Meetings ACCM 2019 Meeting Sponsors ACCM2019 Photos Program Prizes and Frontiers Special Proceeding Issue 2017 ACC Meeting Program Sponsors ACCM 2017…
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2ICSA 2023 - 1 year(s) ago
Welcome We are pleased to announce the 8th International Cell Senescence Association (ICSA) Conference. The conference will be held October 24-27, 2023 at the Graduate Hotel in Minneapolis, Minnesota, hosted by the Institute on the Biology of Aging and Metabolism (iBAM) at the University of Minnesota and the Mayo Clinic Robert and Arlene Kogod Center…
Source: icsa2023minneapolis.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @ICSA_senescence: It is finally here! 🚨🚨🚨 Spread the word #ICSA2023 #senescence >>> https://t.co/N5Mbe38Zij https://t.co/SB8WyoFiox
-
-
Mashup Score: 1Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer | NEJM - 2 year(s) ago
Original Article from The New England Journal of Medicine — Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
Source: New England Journal of MedicineCategories: Latest Headlines, Oncologists1Tweet-
Congratulations to Jeanne Tie on this elegant study presented at #ASCO22 with synchronous publication in @NEJM. Enjoy the day, Jeanne! @PeterMacRes @PeterMacCC @WEHI_Research https://t.co/qr6SJXMQzr
-
-
Mashup Score: 7Transcription cycle | Vervoort Lab - 2 year(s) ago
The Vervoort Lab – Discovery and Targeting of Novel Regulators of RNA Polymerase II in Cancer using cutting-edge genome-engineering, CRISPR-screening and advanced genomics. We are always looking for talented students and postdocs to join the lab!
Source: VervoortLabCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @Stephintje: The Vervoort lab can now be found online! Please check out the lab at: https://t.co/cbLCFgee3m and https://t.co/CoVzsbQdqD…
-
-
Mashup Score: 19Targeting CDK4 and CDK6 in cancer - 2 year(s) ago
Cyclin-dependent kinase 4 (CDK4) and CDK6 are critical mediators of cellular transition into S phase and are important for the initiation, growth and survival of many cancer types. Pharmacological inhibitors of CDK4/6 have rapidly become a new standard of care for patients with advanced hormone receptor-positive breast cancer. As expected, CDK4/6 inhibitors arrest sensitive tumour cells in the G1…
Source: www.nature.comCategories: Latest Headlines, Oncologists1Tweet-
Here's our perspective on targeting CDK4/6, just published in Nature Reviews Cancer @NatureRevCancer @PeterMacRes @UniMelbMDHS @SnowMedical. CDK4/6i's have transformed breast cancer therapy, but we have still only realised a fraction of their potential! https://t.co/9sebdmCG6F https://t.co/iMfuIiDtfg
-
-
Mashup Score: 0Peter Mac - Equifax eRecruit - 2 year(s) ago
Outstanding candidates are encouraged to apply for positions now open at Peter MacCallum Cancer Centre – a place where our normal days are extraordinary; as are the people we care for. Peter Mac is one of a handful of integrated cancer research, education and treatment centres in the world. Each day our team strives to provide the very best in cancer care, even better treatments and…
Source: petermac.mercury.com.auCategories: Hem/Oncs, Latest HeadlinesTweet-
We are hiring! We have just posted an ad for a postdoc to join our growing team in Melbourne. The project will tackle some of the biggest issues in the cancer senescence field, including possible links between senescence and dormancy. Apply if interested: https://t.co/ayzlaCH9AW
-
-
Mashup Score: 21Peter Mac - Equifax eRecruit - 3 year(s) ago
Outstanding candidates are encouraged to apply for positions now open at Peter MacCallum Cancer Centre – a place where our normal days are extraordinary; as are the people we care for. Peter Mac is one of a handful of integrated cancer research, education and treatment centres in the world. Each day our team strives to provide the very best in cancer care, even better treatments and…
Source: petermac.mercury.com.auCategories: Latest Headlines, Oncologists1Tweet-
RT @eckmaslab: Two openings in the lab! Bioinformatic-focused postdoc https://t.co/xmCbOa8UHN Research assistant https://t.co/C3iMA0fri…
-
-
Mashup Score: 1Peter Mac - Equifax eRecruit - 3 year(s) ago
Outstanding candidates are encouraged to apply for the position of Research Officer (single cell genomics) now open at Peter MacCallum Cancer Centre – a place where our normal days are extraordinary; as are the people we care for. Peter Mac is one of a handful of integrated cancer research, education and treatment centres in the world. Each day our team strives to provide the very best…
Source: petermac.mercury.com.auCategories: Latest Headlines, Oncologists1Tweet-
RT @TimJSemple: Interested in cancer research, single cells & genomics? https://t.co/iQVriIJuqX
-
-
Mashup Score: 0
Funders of a deep-pocketed new “rejuvenation” startup are said to include Jeff Bezos and Yuri Milner.
Source: MIT Technology ReviewCategories: Latest Headlines, Oncologists1Tweet-
Wow! https://t.co/l1VKmb1BVz
-
The 2023 Australian Cell Cycle, DNA Repair, & Telomere Meeting is coming! Join us at the Melbourne Museum from October 23-25, and listen to a stellar group of international speakers including Peter Sicinski (Boston), Eiji Hara (Osaka) and many more! https://t.co/Co7m4fruze